SBRA Sabra Health Care REIT, Inc.
Real Estate Investment Trusts · Nasdaq · SEC CIK 1492298 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.4%
TTM net income YoY-59.2%
TTM EPS YoY-61.6%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin7.8%
FCF margin—
EBITDA margin—
Returns
ROE2.5%
ROA1.3%
ROIC (approx.)—
Asset turnover0.17x
Leverage & solvency
Liabilities / assets47.7%
Debt / equity0.86x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.60x
Accruals ratio-6.0%
Payout ratio423.4%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $774.63M | $703.24M | $647.51M | $624.81M | $569.54M |
| SG&A expense | $53.71M | $50.07M | $47.47M | $39.57M | $34.67M |
| Interest expense | $112.49M | $115.27M | $112.96M | $105.47M | $98.63M |
| Pretax income | $153.42M | $128.11M | $18.66M | $21.67M | $80.67M |
| Income tax | $1.84M | $1.00M | $2.00M | $1.24M | $1.84M |
| Net income | $155.61M | $126.71M | $13.76M | -$77.61M | -$113.26M |
| EPS (basic) | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
| EPS (diluted) | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
| Dividends declared per share | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
| Weighted avg. shares (diluted) | 244.50M | 236.05M | 232.79M | 230.95M | 219.07M |
| Balance sheet | |||||
| Cash & equivalents | $71.54M | $66.34M | $46.72M | $53.93M | $115.89M |
| Intangibles | $65.32M | $27.46M | $30.90M | $40.13M | $54.06M |
| Total assets | $5.49B | $5.30B | $5.39B | $5.75B | $5.97B |
| Long-term debt | $2.53B | $2.42B | $2.41B | $2.51B | $2.39B |
| Total debt | $2.53B | $2.42B | $2.41B | $2.51B | $2.39B |
| Total liabilities | $2.67B | $2.56B | $2.58B | $2.69B | $2.59B |
| Shareholders' equity | $2.82B | $2.74B | $2.80B | $3.06B | $3.38B |
| Net debt | $2.46B | $2.35B | $2.37B | $2.45B | $2.28B |
| Shares outstanding | 251.70M | 237.59M | 231.27M | 231.01M | 230.40M |
| Cash flow statement | |||||
| Operating cash flow | $348.61M | $310.54M | $300.57M | $315.73M | $356.39M |
| Investing cash flow | -$377.96M | -$109.00M | $103.13M | -$216.25M | -$336.20M |
| Financing cash flow | $40.76M | -$181.56M | -$410.30M | -$161.71M | $30.14M |
| Depreciation & amortization | $187.00M | $169.62M | $183.09M | $187.78M | $178.99M |
| Stock-based compensation | $11.36M | $8.99M | $7.92M | $7.45M | $7.91M |
| Dividends paid | $289.50M | $280.15M | $277.45M | $277.16M | $262.92M |
Free plan shows the latest 5 periods; Pro shows all 15 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.